These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 21137533

  • 1. [Calprotectin in feces a well-documented marker of gastrointestinal inflammation. Indicates disease intensity--normalization of values predict mucosal healing].
    Lasson A.
    Lakartidningen; ; 107(43):2645-9. PubMed ID: 21137533
    [No Abstract] [Full Text] [Related]

  • 2. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
    Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley EM, Shanahan F.
    Am J Gastroenterol; 2010 Aug; 105(8):1788, 1789-94; quiz 1795. PubMed ID: 20389294
    [Abstract] [Full Text] [Related]

  • 3. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
    Røseth AG, Aadland E, Grzyb K.
    Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
    [No Abstract] [Full Text] [Related]

  • 4. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 5. [Measurement of calprotectin in faeces].
    Jahnsen J, Røseth AG, Aadland E.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):743-5. PubMed ID: 19373299
    [Abstract] [Full Text] [Related]

  • 6. Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome.
    Sprakes MB, Hamlin PJ, Ford AC.
    Am J Gastroenterol; 2011 Jan 16; 106(1):166; author reply 166-7. PubMed ID: 21212757
    [No Abstract] [Full Text] [Related]

  • 7. Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy.
    Long MD, Drossman DA.
    Am J Gastroenterol; 2010 Aug 16; 105(8):1796-8. PubMed ID: 20686466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C, David L, Portincasa P, Dumitraşcu DL.
    Rom J Intern Med; 2012 Aug 16; 50(1):3-6. PubMed ID: 22788087
    [Abstract] [Full Text] [Related]

  • 10. Faecal calprotectin concentrations in gastrointestinal diseases.
    Wang S, Wang Z, Shi H, Heng L, Juan W, Yuan B, Wu X, Wang F.
    J Int Med Res; 2013 Aug 16; 41(4):1357-61. PubMed ID: 23723365
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.
    Ann Clin Biochem; 2004 May 16; 41(Pt 3):230-2. PubMed ID: 15117438
    [Abstract] [Full Text] [Related]

  • 12. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
    Gearry R, Barclay M, Florkowski C, George P, Walmsley T.
    N Z Med J; 2005 May 06; 118(1214):U1444. PubMed ID: 15886739
    [No Abstract] [Full Text] [Related]

  • 13. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov 06; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 14. What is the faecal calprotectin test?
    Drug Ther Bull; 2014 Sep 06; 52(9):102-4. PubMed ID: 25213590
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The semi-quantitative calprotectin rapid test--is it useful in inflammatory bowel disease?
    Dranga M, Dumitrescu G, Badea M, Blaj A, Mihai C, Prelipcean CC.
    Rev Med Chir Soc Med Nat Iasi; 2012 Sep 06; 116(3):761-5. PubMed ID: 23272524
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Forbes A, Bjarnason I, Sherwood RA, Ciclitira P, Nicholls JR.
    Eur J Gastroenterol Hepatol; 2008 Mar 06; 20(3):174-9. PubMed ID: 18301296
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion.
    Rogler G, Aldeguer X, Kruis W, Lasson A, Mittmann U, Nally K, Peyrin-Biroulet L, Schoepfer A, Vatn M, Vavricka S, Logan R.
    J Crohns Colitis; 2013 Sep 06; 7(8):670-7. PubMed ID: 23517932
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.